Your browser doesn't support javascript.
loading
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.
Jiang, Yi-Zhou; Liu, Yin; Xiao, Yi; Hu, Xin; Jiang, Lin; Zuo, Wen-Jia; Ma, Ding; Ding, Jiahan; Zhu, Xiaoyu; Zou, Jianjun; Verschraegen, Claire; Stover, Daniel G; Kaklamani, Virginia; Wang, Zhong-Hua; Shao, Zhi-Ming.
Afiliação
  • Jiang YZ; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Liu Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Xiao Y; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Jiang L; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Zuo WJ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Ma D; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Ding J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Zhu X; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Zou J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Verschraegen C; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Stover DG; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Kaklamani V; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
  • Wang ZH; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Shao ZM; Department of Breast Surgery, Fudan University Shanghai Cancer Center; Key Laboratory of Breast Cancer in Shanghai, Shanghai, 200032, China.
Cell Res ; 31(2): 178-186, 2021 02.
Article em En | MEDLINE | ID: mdl-32719455
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Medicina de Precisão / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imuno-Histoquímica / Medicina de Precisão / Sequenciamento de Nucleotídeos em Larga Escala / Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article